US Stock MarketDetailed Quotes

UPC Universe Pharmaceuticals

Watchlist
  • 3.7400
  • +0.1600+4.47%
Close Jul 26 16:00 ET
  • 3.6011
  • -0.1389-3.71%
Post 19:32 ET
88.44MMarket Cap-2200P/E (TTM)

Universe Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2023
(FY)Sep 30, 2022
(FY)Sep 30, 2021
(FY)Sep 30, 2020
(FY)Sep 30, 2019
(FY)Sep 30, 2018
Total revenue
-19.52%32.31M
-16.34%40.14M
56.27%47.98M
-7.60%30.7M
16.54%33.23M
28.51M
Operating revenue
-19.52%32.31M
-16.34%40.14M
56.27%47.98M
-7.60%30.7M
16.54%33.23M
--28.51M
Cost of revenue
20.50%21.99M
-19.44%18.25M
36.40%22.66M
-16.20%16.61M
31.22%19.82M
15.11M
Gross profit
-52.88%10.32M
-13.56%21.89M
79.70%25.33M
5.12%14.09M
-0.01%13.41M
13.41M
Operating expense
-50.60%14.28M
141.60%28.91M
219.61%11.97M
11.54%3.74M
-8.01%3.36M
3.65M
Selling and administrative expenses
-56.80%9M
244.79%20.84M
116.21%6.04M
21.93%2.8M
-3.88%2.29M
--2.39M
-Selling and marketing expense
-64.45%6.78M
541.77%19.08M
91.16%2.97M
-1.47%1.56M
-6.04%1.58M
--1.68M
-General and administrative expense
26.48%2.22M
-42.89%1.75M
147.64%3.07M
73.69%1.24M
1.25%713.65K
--704.87K
Research and development costs
-36.44%4.86M
39.86%7.64M
837.31%5.47M
-5.71%583.13K
-21.66%618.44K
--789.38K
Depreciation amortization depletion
5.55%195.45K
7.37%185.17K
-8.60%172.45K
-9.81%188.67K
-10.53%209.19K
--233.81K
-Depreciation and amortization
5.55%195.45K
7.37%185.17K
-8.60%172.45K
-9.81%188.67K
-10.53%209.19K
--233.81K
Other taxes
-12.84%179.19K
-8.21%205.58K
44.25%223.98K
-9.02%155.27K
-6.38%170.66K
--182.29K
Other operating expenses
19.21%47.15K
-35.09%39.56K
179.22%60.94K
-66.89%21.83K
12.61%65.92K
--58.54K
Operating profit
43.50%-3.97M
-152.54%-7.02M
29.08%13.36M
2.98%10.35M
2.98%10.05M
9.76M
Net non-operating interest income expense
3.46%-156.79K
-59.84%-162.4K
17.90%-101.6K
4.26%-123.76K
21.62%-129.27K
-164.92K
Non-operating interest expense
-3.46%156.79K
59.84%162.4K
-17.90%101.6K
-4.26%123.76K
-21.62%129.27K
--164.92K
Other net income (expense)
134.07%273.32K
-290.97%-802.3K
434.40%420.12K
53.20%-125.63K
-249.56%-268.47K
-76.8K
Gain on sale of security
108.19%38.53K
-296.40%-470.48K
--239.55K
----
----
----
Earnings from equity interest
-19.48%31.07K
25.18%38.59K
41.28%30.83K
-18.40%21.82K
23.63%26.74K
--21.63K
Special income (charges)
204.76%439.33K
-282.19%-419.35K
334.63%230.18K
67.08%-98.1K
-188.05%-297.97K
---103.45K
-Write off
-204.76%-439.33K
282.19%419.35K
-334.63%-230.18K
-67.08%98.1K
188.05%297.97K
--103.45K
Other non- operating income (expenses)
-581.43%-235.61K
160.84%48.94K
-62.98%-80.43K
-1,888.12%-49.35K
-44.95%2.76K
--5.01K
Income before tax
51.78%-3.85M
-158.37%-7.98M
35.42%13.68M
4.63%10.1M
1.42%9.65M
9.52M
Income tax
207.47%2.31M
-68.10%752.42K
-7.23%2.36M
20.97%2.54M
9.74%2.1M
1.92M
Net income
29.46%-6.16M
-177.18%-8.74M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Net income continuous Operations
29.46%-6.16M
-177.18%-8.74M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
--7.6M
Minority interest income
Net income attributable to the parent company
29.46%-6.16M
-177.18%-8.74M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.46%-6.16M
-177.18%-8.74M
49.77%11.32M
0.09%7.56M
-0.68%7.55M
7.6M
Basic earnings per share
29.46%-1.7
-167.32%-2.41
65.78%3.58
0.09%2.1595
-0.68%2.1576
2.1723
Diluted earnings per share
29.46%-1.7
-167.32%-2.41
65.78%3.58
0.09%2.1595
-0.68%2.1576
2.1723
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
Unqualified Opinion
--
--
(FY)Sep 30, 2023(FY)Sep 30, 2022(FY)Sep 30, 2021(FY)Sep 30, 2020(FY)Sep 30, 2019(FY)Sep 30, 2018
Total revenue -19.52%32.31M-16.34%40.14M56.27%47.98M-7.60%30.7M16.54%33.23M28.51M
Operating revenue -19.52%32.31M-16.34%40.14M56.27%47.98M-7.60%30.7M16.54%33.23M--28.51M
Cost of revenue 20.50%21.99M-19.44%18.25M36.40%22.66M-16.20%16.61M31.22%19.82M15.11M
Gross profit -52.88%10.32M-13.56%21.89M79.70%25.33M5.12%14.09M-0.01%13.41M13.41M
Operating expense -50.60%14.28M141.60%28.91M219.61%11.97M11.54%3.74M-8.01%3.36M3.65M
Selling and administrative expenses -56.80%9M244.79%20.84M116.21%6.04M21.93%2.8M-3.88%2.29M--2.39M
-Selling and marketing expense -64.45%6.78M541.77%19.08M91.16%2.97M-1.47%1.56M-6.04%1.58M--1.68M
-General and administrative expense 26.48%2.22M-42.89%1.75M147.64%3.07M73.69%1.24M1.25%713.65K--704.87K
Research and development costs -36.44%4.86M39.86%7.64M837.31%5.47M-5.71%583.13K-21.66%618.44K--789.38K
Depreciation amortization depletion 5.55%195.45K7.37%185.17K-8.60%172.45K-9.81%188.67K-10.53%209.19K--233.81K
-Depreciation and amortization 5.55%195.45K7.37%185.17K-8.60%172.45K-9.81%188.67K-10.53%209.19K--233.81K
Other taxes -12.84%179.19K-8.21%205.58K44.25%223.98K-9.02%155.27K-6.38%170.66K--182.29K
Other operating expenses 19.21%47.15K-35.09%39.56K179.22%60.94K-66.89%21.83K12.61%65.92K--58.54K
Operating profit 43.50%-3.97M-152.54%-7.02M29.08%13.36M2.98%10.35M2.98%10.05M9.76M
Net non-operating interest income expense 3.46%-156.79K-59.84%-162.4K17.90%-101.6K4.26%-123.76K21.62%-129.27K-164.92K
Non-operating interest expense -3.46%156.79K59.84%162.4K-17.90%101.6K-4.26%123.76K-21.62%129.27K--164.92K
Other net income (expense) 134.07%273.32K-290.97%-802.3K434.40%420.12K53.20%-125.63K-249.56%-268.47K-76.8K
Gain on sale of security 108.19%38.53K-296.40%-470.48K--239.55K------------
Earnings from equity interest -19.48%31.07K25.18%38.59K41.28%30.83K-18.40%21.82K23.63%26.74K--21.63K
Special income (charges) 204.76%439.33K-282.19%-419.35K334.63%230.18K67.08%-98.1K-188.05%-297.97K---103.45K
-Write off -204.76%-439.33K282.19%419.35K-334.63%-230.18K-67.08%98.1K188.05%297.97K--103.45K
Other non- operating income (expenses) -581.43%-235.61K160.84%48.94K-62.98%-80.43K-1,888.12%-49.35K-44.95%2.76K--5.01K
Income before tax 51.78%-3.85M-158.37%-7.98M35.42%13.68M4.63%10.1M1.42%9.65M9.52M
Income tax 207.47%2.31M-68.10%752.42K-7.23%2.36M20.97%2.54M9.74%2.1M1.92M
Net income 29.46%-6.16M-177.18%-8.74M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Net income continuous Operations 29.46%-6.16M-177.18%-8.74M49.77%11.32M0.09%7.56M-0.68%7.55M--7.6M
Minority interest income
Net income attributable to the parent company 29.46%-6.16M-177.18%-8.74M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.46%-6.16M-177.18%-8.74M49.77%11.32M0.09%7.56M-0.68%7.55M7.6M
Basic earnings per share 29.46%-1.7-167.32%-2.4165.78%3.580.09%2.1595-0.68%2.15762.1723
Diluted earnings per share 29.46%-1.7-167.32%-2.4165.78%3.580.09%2.1595-0.68%2.15762.1723
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified OpinionUnqualified OpinionUnqualified OpinionUnqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg